Alps Advisors Inc Relay Therapeutics, Inc. Transaction History
Alps Advisors Inc
- $17.2 Billion
- Q2 2025
A detailed history of Alps Advisors Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 92,528 shares of RLAY stock, worth $682,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,528Holding current value
$682,856% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
212Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$206 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$99.2 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$98.5 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$84.1 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$77.8 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $887M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...